Legacy Pharmaceutical Packaging LLC 2024-01-03 Health serious FDA
Health · FDA · Recall #FDA-D-0205-2024
Sertraline Tablets, USP 100 mg, 30 tablets per bottle, Distributed by: Wal-Mart,… Recall
Issued January 3, 2024 · Legacy Pharmaceutical Packaging LLC
In January 2024, Legacy Pharmaceutical Packaging LLC recalled the Sertraline Tablets, USP 100 mg, 30 tablets per bottle, Distributed by: Wal-Mart,…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
CGMP Deviations: Inadequate line clearance which may result in a potential comingling of product.
What you should do
- 1 Stop using Sertraline Tablets, USP 100 mg, 30 tablets per bottle, Distributed by: Wal-Mart,… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Legacy Pharmaceutical Packaging LLC to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Legacy Pharmaceutical Packaging LLC
- Category
- Health
- Recall date
- January 3, 2024
- Units affected
- Not reported
- Sold at
- CA and AR
- Recall number
- FDA-D-0205-2024
- Made in
- United States
- Issuing agency
- FDA
In context
- Legacy Pharmaceutical Packaging LLC has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 737th Health recall we've logged in 2024.